Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Franki Speleman
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
114
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor-spokesperson
01 January 2022 → 31 December 2025
Replication fork protector dependency factors: novel targets for combination treatment and immunomodulation in neuroblastoma (REINFORCE)
Funding: Regional and community funding: Special Research Fund
01 January 2023 → 31 December 2026
Spatial-omics deciphering of cellular and molecular responses to enhanced MYCN/ATR-CHK1 synthetic lethality in high-risk neuroblastoma
Funding: Research Foundation - Flanders (FWO)
As
Promotor
01 March 2011 → 31 December 2014
A DNA methylation signature as biomarker for prognosis in children with neuroblastoma
Funding: Funding by bilateral agreement (private and foundations)
01 March 2010 → 28 February 2013
A DNA methylation signature as biomarker for prognosis in children with neuroblastoma
Funding: Funding by bilateral agreement (private and foundations)
01 November 2019 → 31 October 2023
A human pluripotent stem cell derived differentiation model for the study of normal and transformed sympathoadrenal progenitors
Fellow: Stéphane Van Haver
Funding: Research Foundation - Flanders (FWO)
01 November 2010 → 30 April 2016
Analysing and Striking the Sensitivities of Embryonal Tumours
Funding: European funding: framework programme
01 October 2011 → 30 September 2015
An epigenetic DNA modification signature as a biomarker for prognosis in children with neuroblastoma
Fellow: Anneleen Decock
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 May 2018 → 30 April 2022
An integrated functional proteomics platform for the study of normal development and disease
Funding: Research Foundation - Flanders (FWO)
01 October 2007 → 30 September 2011
Array comparative genomic hybridization (Array CGH)
Funding: Regional and community funding: various
01 October 2007 → 17 March 2008
Array comparative genomic hybridization (array CGH) study of submicroscopic genomic rearrangements in patients with unexplained mental retardation.
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 October 2018 → 30 September 2019
Beurs EVDS Siebe Loontiens: Unraveling the functionality of PHF6 in normal and malignant T-cell development and its cooperativity with established oncogenes through zebrafish modeling
Fellow: Siebe Loontiens
Funding: Funding by bilateral agreement (private and foundations)
01 October 2017 → 31 December 2020
BRIP1 and FOXM1 controlling replication stress in the neuroblastoma tumor genome
Fellows: Suzanne Vanhauwaert
Funding: Research Foundation - Flanders (FWO)
01 November 2020 → 31 October 2024
BRIP1 controlling replicative stress in the neuroblastoma tumor genome: functional exploration and zebrafish modelling
Fellow: Elien Hilgert
Funding: Research Foundation - Flanders (FWO)
01 April 2012 → 31 December 2017
Cancer cells and their microenvironment: from gene regulatory networks to therapy
Funding: Federal funding: various
01 October 2007 → 01 October 2008
Characterisation and in vivo validation of the therapeutic potential of JAK/STAT antagonists in neuroblastoma
Funding: Regional and community funding: Special Research Fund
01 October 2010 → 30 September 2014
Characterization of the p53 network and exploration of p53-dependent and p53-independent molecular therapy in neuroblastoma
Funding: Regional and community funding: Special Research Fund
01 October 2016 → 31 December 2020
Computational probing of replicative stress resistance and induced G-quadruplex resolving processes in embryonic stem or cancer cells
Fellows: Christophe Van Neste
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 31 December 2009
Construction of a tissue array for 'high-troughput' detection of genomic aberrations and protein profiling in neuroblastoom
Funding: Research Foundation - Flanders (FWO)
01 January 2010 → 31 October 2016
Deregulated transcriptional networks of regulatory miRNAs and protein coding genes in the pathogenesis of cancer
Funding: Regional and community funding: Special Research Fund
01 January 2016 → 31 December 2019
Drug resistance in MYC/MYCN driven tumor entities as a consequence of replicative stress induced DNA damage response: an entry point for synthetic lethal drugs
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 30 September 2016
Dual targeting of ALK and RET: establishing a novel basis for the treatment of neuroblastoma
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2017
Dynamic interplay between DNA mehtylation, histone modifications and the activity of super enhancers in the pathogenesis of immature T-ALL
Funding: Funding by bilateral agreement (private and foundations)
01 October 2015 → 30 September 2019
Epigenetic re-activation of T-ALL tumor suppressors under control of TLX1driven enhancer RNAs.
Fellows: Karen Verboom
Funding: Regional and community funding: Special Research Fund
01 May 2016 → 31 July 2020
ERAcoSysMed _ JTC 2015 OPTIMIZE NOTE: Optimizing the first-line therapy for aggressive neuroblastoma system by medical strategies against secondary resistance.
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 31 December 2009
European Embryonal Tumor Pipeline
Funding: European funding: framework programme
01 January 2011 → 31 December 2015
European Network for Cancer research in Children and Adolescents (ENCCA)
Funding: European funding: framework programme
01 January 2015 → 31 December 2017
Exploring the TLX1-PHF6 cooperative interrelationship in T-cell acute lymphoblastic leukemia through zebrafish modeling
Funding: Funding by bilateral agreement (private and foundations)
01 October 2014 → 30 September 2018
Exploring the TLX1-PHF6 cooperative interrelationship in T-cell acute lymphoblastic leukemia through zebrafish modeling
Fellow: Siebe Loontiens
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2007 → 31 December 2011
From genes to functional defects in hereditary and malignant diseases
Funding: Federal funding: various
01 October 2012 → 30 September 2016
Functional study of the ALK-F1174 mutation in
Fellow: Shana Claeys
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2009 → 30 December 2011
Genetic and functional study of MYCN target genes in signaling and metabolic pathways and their therapeutic potential in neuroblastoma.
Funding: Research Foundation - Flanders (FWO)
01 October 2013 → 30 September 2014
Genetic defects in chromatin regulators in T-cell acute lymphoblastic leukemia
Funding: Funding by bilateral agreement (private and foundations)
15 October 2007 → 31 December 2010
Genome wide screening for methylation defects, nonsense mutaions and tumour-related microRNA expression profiles in neuroblastoma
Funding: Regional and community funding: Special Research Fund
01 November 2018 → 31 October 2023
Genomic analyses of liquid biopsies for diagnosis, monitoring and therapeutic stratification of paediatric cancers.
Funding: Funding by bilateral agreement (private and foundations)
01 October 2007 → 30 September 2009
Genomic and transcriptoomproflering neuroblastoma: identification of prognostic diagnostic expression signatures, unraveling the MYCN transcriptional network and study of the biological role v chromosome 17q gain..
Fellow: Jo Vandesompele
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 October 2016 → 30 September 2017
HBP1 as novel therapeutic target in ALK- and MYCN-driven neuroblastoma
Fellow: Shana Claeys
Funding: Funding by bilateral agreement (private and foundations)
01 January 2013 → 31 December 2018
Identification and study of NOTCH1 regulated long noncoding RNAs driving T-cell acute lymphoblastic leukemia formation
Funding: Research Foundation - Flanders (FWO)
01 October 2008 → 30 September 2014
Identification of critical on mTOR effector pathways in NF1-related tumorigenesis
Fellow: Ophélia Maertens
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2009 → 30 December 2011
Identification of deregulated microRNA expression in T-cell acute lymphoblastic leukemia by use of microRNA specific arrayCGH
Funding: Research Foundation - Flanders (FWO)
01 October 2007 → 30 September 2011
Identification of direct and miRNA-regulated MYCN target genes and analysis of their involvement in signaling pathways and epigenetic control.
Funding: Regional and community funding: Special Research Fund
01 October 2016 → 30 September 2019
Identification of novel therapeutic targets through multi-level (epi) genomic landscaping of replicative stress resistant neuroblastoma
Fellows: Kaat Durinck
Funding: Regional and community funding: Special Research Fund
01 January 2011 → 31 December 2011
Identification of perturbed miRNAs during neuroblasoma development using neuroblasts as normal counterparts
Funding: Funding by bilateral agreement (private and foundations)
01 January 2018 → 31 December 2018
IncuCyte S3 Live-Cell Analysis System
Funding: Funding by bilateral agreement (private and foundations)
01 January 2008 → 30 December 2013
Integrated molecular profiling in neuroblastoma: identification of new molecular therapeutic targets and optimalised prognostic classification
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2018
Integration of long noncoding RNAs in miRNA/mRNA regulatory networks in t-cell acute lymphoblastic leukemia
Funding: Research Foundation - Flanders (FWO)
01 October 2015 → 30 September 2020
Investigation of the Polycomb-associated RNA sequence space and functional consequences
Fellows: Lieselot Carrette
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2016 → 31 October 2021
Long noncoding RNAs in cancer: deciphering the functional role of the dark matter of the human cancer genome
Funding: Regional and community funding: Special Research Fund
01 January 2008 → 31 December 2010
MicroRNA's in neuroblastoma
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 30 April 2009
Molecular signature recognition for improved diagnosis, prognosis and follow-up in neuroblastoma
Funding: Funding by bilateral agreement (private and foundations)
01 October 2011 → 30 September 2014
Molecular therapy of neuroblastoma: a p53-oriented appraoch
Fellow: Tom Van Maerken
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2007 → 31 December 2010
MYCN deregulated transcription in neuroblastome: study of direct mRNA and miRNA regulated target genes
Funding: Funding by bilateral agreement (private and foundations)
01 October 2016 → 31 December 2021
Novel combination therapies to combat therapy resistant neuroblastoma: translating pre-clinical investigations to clinical trials
Funding: Funding by bilateral agreement (private and foundations)
01 January 2010 → 31 December 2015
PHF6: a new tumor suppressor gene in T-cell acute lymphoblastic leukemia
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2015
Preclinical evaluation of the nutlin molecule RG7112 in neuroblastoma
Fellow: Tom Van Maerken
Funding: Research Foundation - Flanders (FWO)
01 January 2024 → 31 December 2024
Preclinical investigation of RRM2-CHK1 combinatorial drugging in neuroblastoma
Funding: Regional and community funding: Special Research Fund
01 January 2016 → 31 March 2017
purchase of a technical platform
Funding: Research Foundation - Flanders (FWO)
01 October 2007 → 30 September 2008
Quantitative proteome analysis of MYCN oncoprotein function and identification of molecular therapeutic targets in the neuroblastoma
Fellow: Tom Van Maerken
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2015
Reconstructing m(i)RNA regulatory networks implicated in invasion and metastasis in neuroblastoma
Fellow: Katleen De Preter
Funding: Research Foundation - Flanders (FWO)
01 January 2012 → 31 December 2017
Reconstruction of dynamic initiation and progression gene expression regulatory networks in neuroblastoma
Funding: Research Foundation - Flanders (FWO)
01 January 2012 → 31 December 2017
Reconstruction of functional molecular networks in ALK mutated neuroblastomas
Funding: Research Foundation - Flanders (FWO)
01 January 2014 → 31 December 2017
Reduction of chemotherapy driven late adverse effects through targeted molecular therapies in high-risk pediatric cancers
Funding: Research Foundation - Flanders (FWO)
01 January 2016 → 31 December 2019
Replicative stress induced DNA damage response signaling at the crossroad between embryonic stem cells and MYC(N) driven tumours
Funding: Research Foundation - Flanders (FWO)
01 October 2015 → 30 September 2016
Research Grant Emmanuel Van de Schueren to Suzanne Vanhauwaert: BRIP1 and BIRC5 as novel therapeutic targets in neuroblastoma
Fellow: Suzanne Vanhauwaert
Funding: Research Foundation - Flanders (FWO)
01 October 2016 → 30 September 2020
RRM2 controlled replicative stress resistance as a druggable DNA copy number driven cell state in MYC(N) driven cancers
Fellows: Carolina de Carvalho Nunes
Funding: Research Foundation - Flanders (FWO)
01 March 2014 → 28 February 2017
RUNX2 as a driver of poor prognostic early T-cell progenitor leukemia
Fellow: Filip Matthijssens
Funding: Funding by bilateral agreement (private and foundations)
01 October 2011 → 10 October 2014
Selection of driver genes and neuronal differentiation gene modules in neuroblastoma through an integrated genomic analysis
Fellow: Annelies Fieuw
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 November 2019 → 31 December 2021
SOX11 as mediator of the adrenergic cell state in neuroblastoma: towards cell precision medicine
Fellow: Bieke Decaesteker
Funding: Research Foundation - Flanders (FWO)
01 January 2011 → 31 December 2014
STAND UP TO CANCER: Integration of individual cancer genes in signalisation network in pediatric tumors
Funding: Research Foundation - Flanders (FWO)
01 December 2017 → 30 November 2018
Startersbeurs EVDS Lisa Depestel: The chromatin modifier PHF6 as adaptor in gene-gating coupled replicative stress in neuroblastoma and T-ALL
Fellows: Lisa Depestel
Funding: Funding by bilateral agreement (private and foundations)
01 October 2007 → 30 September 2014
Study of neuroblastoma oncogenesis through mRNA and miRNA expression profiling of normal neuroblasts and neuroblastoma stem cells
Fellow: Katleen De Preter
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2017
Targeting the leukemic cancer stem cell in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL)
Funding: Funding by bilateral agreement (private and foundations)
01 January 2018 → 31 December 2018
The chromatin modifier BRD3 as a key novel player in DNA repair and vulnerable therapeutic target in neuroblastoma
Fellows: Kaat Durinck
Funding: Research Foundation - Flanders (FWO)
01 January 2018 → 31 December 2021
The chromatin modifier PHF6 as adaptor in gene-gating coupled replicative stress in neuroblastoma and T-ALL
Funding: Research Foundation - Flanders (FWO)
01 October 2012 → 30 September 2018
The function of PHF6 in normal T-cell development and T-cell acute lymphoblastic leukemia
Fellow: Pieter Rondou
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 October 2019 → 30 July 2024
The PHF6 - TLX1 cooperativity and the IL7R-JAK3 signaling axis as drug target in PHF6 deficient TALL.
Funding: Regional and community funding: Special Research Fund
01 January 2015 → 31 December 2015
The PHF6 - TLX1 cooperativity and the IL7R-JAK3 signaling axis as drug target in PHF6 deficient T-ALL
Fellow: Kaat Durinck
Funding: Research Foundation - Flanders (FWO)
01 October 2018 → 31 August 2021
The role of BRCA1 as oncogenic replicative stress resistor in MYCN driven neuroblastoma
Fellow: Kaat Durinck
Funding: Research Foundation - Flanders (FWO)
01 January 2021 → 31 December 2024
The role of BRIP1 in MYCN driven neuroblastoma formation: from mechanism to drugging
Funding: Research Foundation - Flanders (FWO)
01 October 2012 → 30 September 2016
The role of long noncoding RNAs in T-cell acute lymphoblastic leukemia
Fellow: Annelynn Wallaert
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 October 2008 → 30 September 2014
The role of microRNA's in the pathogenesis of T-cell acute lymphoblastic leukemia
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2009 → 31 December 2014
The role of miRNA expression in normal and malignant T-cel development
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 05 January 2016
The role of miRNAs in neuroblastoma tumor initiation
Fellow: Anneleen Beckers
Funding: Regional and community funding: IWT/VLAIO
01 October 2009 → 30 September 2013
The role of PHF6 in normal and malign T-cell development.
Fellow: Joni Van der Meulen
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2011 → 31 December 2014
The role of PHF6 in normal T-cell development and T-cell acute lymphoblastic leukemia
Funding: Funding by bilateral agreement (private and foundations)
09 December 2010 → 08 December 2011
The role of PHF6 in normal T-cell development and T-cell acute lymphoblastic leukemia
Funding: Funding by bilateral agreement (private and foundations)
01 November 2019 → 31 October 2023
The role of super-enhancer regulated SOX11 in regulation of SWI/SNF and PRC2 activity in adrenergic neuroblastoma
Fellow: Amber Louwagie
Funding: Research Foundation - Flanders (FWO)
01 October 2012 → 30 September 2016
The role of the ETS transcription factor ETV5 as executer of ALK oncogenic signaling
Fellow: Irina Lambertz
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 October 2021 → 30 September 2025
The role of the SOX11 lineage-dependency factor as epigenetic master regulator in neuroblastoma
Funding: Regional and community funding: Special Research Fund
01 January 2016 → 31 December 2019
The TLX1 epigenetic enhancer lncRNAome in T-cell acute lymphoblastic leukemia
Funding: Research Foundation - Flanders (FWO)
01 January 2016 → 30 June 2020
Transcan-2 cofund JTC 2014
Funding: Research Foundation - Flanders (FWO)
01 January 2011 → 31 December 2013
Unraveling the role of PHF6 in normal T cell development and T-cell acute leukemia
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 30 November 2014
Unraveling the role of PHF6 in normal T-cell development and T-cell acute leukemia
Fellow: Pieter Rondou
Funding: Regional and community funding: Special Research Fund
01 October 2010 → 05 January 2016
Unraveling the role of PHF6 in normal T cell development and T-cell acute lymphoblastic leukemia
Fellow: Kaat Durinck
Funding: Regional and community funding: IWT/VLAIO
01 May 2024 → 30 April 2025
Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students
Fellow: Joshua Robert Goulding
Funding: Regional and community funding: Special Research Fund
01 December 2020 → 30 November 2024
Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students
Funding: European funding: framework programme
01 January 2020 → 31 December 2021
Validation of ferroptosis-sensitizing combination therapies in patient-derived neuroblastoma models
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2017
Zebrafish modeling of neuroblastoma: novel tools for "accelerated" driver gene discovery and pre-clinical testing
Funding: Funding by bilateral agreement (private and foundations)
01 January 2015 → 31 December 2017
Zebrafish transgenic and patient xenograft transplantation models of pediatric tumors for the pre-clinical drug testing
Funding: Funding by bilateral agreement (private and foundations)
As
Copromotor
01 May 2022 → 30 April 2026
A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapies
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 30 September 2012
Deciphering the molecular pathogenesis of neuroblastoma through next generation genome analysis
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 May 2024 → 30 April 2028
FullPicture: Combining Spectral Flow Cytometry with High-Speed Cell Imaging to enable comprehensive profiling of plant and animal cells and their components in real time.
Funding: Research Foundation - Flanders (FWO)
01 October 2008 → 30 September 2012
Identification of causal mutations in patients with unexplained mental retardation and congenital abnormalities by high throughput sequencing of selected candidate genes
Fellow: Sarah Vergult
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2022
Improved outcome prediction of children with neuroblastoma using an integrated m/miRNA and DNA methylation signature (Stichting tegen Kanker)
Funding: Funding by bilateral agreement (private and foundations)
15 December 2022 → 14 December 2024
Incucyte S3: Comprehensive cellular phenotyping using high-throughput live cell imaging
Funding: Regional and community funding: Special Research Fund
15 June 2012 → 30 June 2016
IVIS Lumina II Bioluminescence camera for laboratory animal research
Funding: Regional and community funding: Special Research Fund
01 June 2015 → 31 May 2017
Longitudinal imaging of cellular dynamics with a biostation IM-Q (microscope with sensitive CCD camera and integrated incubator)
Funding: Regional and community funding: Special Research Fund
01 January 2016 → 31 December 2022
Long noncoding RNAs in cancer: deciphering the functional role of the dark matter of the human cancer genome
Funding: Regional and community funding: Special Research Fund
01 May 2024 → 30 April 2028
Photolithographic DNA printer for massively parallel synthesis of DNA oligonucleotides for spatial - omics and hybrid capture target enrichment applications
Funding: Research Foundation - Flanders (FWO)
01 November 2021 → 31 October 2025
Scrutinizing selective Aurora Kinase A inhibition as a novel entry point for synthetic lethality in neuroblastoma
Fellow: Muhammad Rishfi
Funding: Research Foundation - Flanders (FWO)
01 May 2022 → 30 April 2026
SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomics
Funding: Research Foundation - Flanders (FWO)
01 May 2020 → 30 April 2024
Stimulated emission depletion microscopy (STED): Nanoscopy for innovative research in the life sciences
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 30 December 2012
Study on the envolvement of LEMD3 and neighbouring genes on 12q14 in the pathogenesis of conditions with elevated bone density and growth disordes
Funding: Research Foundation - Flanders (FWO)
01 November 2020 → 31 October 2024
Targeting the degradation of proteins involved in neuroblastoma with bivalent ligands.
Fellow: Simon Krols
Funding: Research Foundation - Flanders (FWO)
01 May 2024 → 30 April 2028
ThirdGenT: linking third-generation sequencing of (epi)genomes, (epi)transcriptomes and translatomes to life sciences revolutionizes oncology, rare diseases, microbiology, cell and gene technology, developmental and computational biology
Funding: Research Foundation - Flanders (FWO)